Tissue implant

Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C623S016110

Reexamination Certificate

active

06306169

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a tissue implant for use in damaged load-bearing cartilaginous tissue, such as the meniscus and articular cartilage.
2. Related Art
Many non-calcified skeletal connective tissues such as articular cartilage, menisci, ligaments, tendons and intervertebral disc have a mechanical function and, as such, are subjected to dynamic mechanical loading during physiological activity. For example, joint forces are considerable during normal physiological activities and commonly exceed 2000 N or three times body weight and occur repetitively approximately 1 million times per year. Thus articular cartilage will be commonly subjected to contact stresses exceeding 5 MPa.
The cartilaginous tissues are composed of cells embedded within an extensive extracellular matrix. The functional behaviour of these tissues is best understood when it is considered as biphasic consisting of a fluid phase of interstitial water containing dissolved inorganic salts and a solid phase containing the collagen-proteoglycan organic solid matrix. The two phases together permit fluid flow through the permeable solid phase. It is the physicochemical interaction of the various components of the extracellular matrix which is responsible for the mechanical properties of the healthy tissues. For example in articular cartilage, there is a physico-chemical equilibrium between the osmotic swelling pressure (P
swelling
) of the proteoglycan gel which is balanced by the hydrostatic pressures (P
elastic
) due to the tensile stresses generated within the collagen fibre network. This balance exists even in unloaded articular cartilage. It is altered when the tissue is loaded in compression by an applied hydrostatic pressure (P
applied
) resulting in a net pressure differential (&Dgr;p) and fluid flow away from the compressed tissue. The appropriate equation is given by
 &Dgr;
p=P
applied
+(
P
elastic
−P
swelling
)
This fluid flow will result in an increased proteoglycan concentration within the tissue and a change in the relative magnitudes of the stresses in the two solid components of articular cartilage. If the compressive load remains constant the rate of fluid flow decreases with time and eventually reduces to zero at a new state of equilibrium. This time-dependent creep behaviour is characteristic of all viscoelastic soft tissues.
The cells, although occupying less than 10% of the tissue volume, are necessary for the synthesis and maintenance of matrix levels and are, therefore, crucial to the structural integrity and function of the tissue. It is known that the cells, whether chondrocytes in cartilage, fibrochondrocytes in menisci, or tenocytes and fibroblasts in tendon and ligament respectively, are able to alter their metabolic activity in response to applied loads. Both the level of strain applied and the dynamic frequency are known to be important in determining this response. These processes are believed to be major factors in determining cellular activity in these tissues.
The mechanisms by which cells detect and respond to mechanical load are termed mechanotransduction pathways and are complex and poorly understood. mechanotransduction events may be resolved into extracellular components including cell deformation, hydrostatic pressures and streaming potentials, followed by intracellular signalling events such as intracellular calcium fluxes, cAMP production and cytoskeletal alterations which finally lead to altered effector cell response. However, understanding such mechanisms has been complicated by the need to investigate the processes at a number of different levels, including the cellular level.
Injuries to soft tissues are extremely common in hospital clinics. Indeed, soft tissue replacements amount to an estimated 35% of the world market for all medical devices (Materials Technology Foresight in Biomaterials, Institute of Materials, London (1995).
In the case of articular cartilage and knee menisci, traumatic damage is common in young active people. Natural repair is often poor due to limited vascularity. If untreated, damage commonly leads to progressive degenerative changes, such as osteoarthritis, in the injured tissue and associated structures. Current solutions, include the use of artificial joints but these implants have a relatively short lifespan of 12-15 years with subsequent replacements lasting for shorter periods. This is a special problem for patients who have received an implant early in life.
There have been many options proposed for the repair of soft tissues. These generally involve synthetic materials, biological materials or a combination of the two. The former solutions have the advantages of providing a structure which is immunologically acceptable and with the mechanical integrity required of load bearing structures. However their instability in the body leads to relatively poor long term performance. Biological solutions traditionally involve autografts, allografts or xenografts, depending on their source of tissues. Each of these options has proved to be far from ideal with, for example, autografts leading to donor site morbidity and allografts and xenografts leading to graft rejection.
Other common solutions involve augmentation devices incorporating both synthetic structures and biological grafts. These devices depend on tissue ingrowth and regeneration induced by the successful transfer of stress from the synthetic material to the natural tissues. This stress transfer process would need to change with time after implantation as the tissue regenerates. Clinical reports are not generally convincing due to, for example, the inadequate initial performance of the synthetic component of the augmentation device.
Commonly used procedures for treatment of articular cartilage lesions include the Pridie technique which involves drilling or abrasion of the joint surface to release repair cells which form a fibrocartilaginous repair tissue. Other procedures involve the use of carbon fibre rods or mats associated with drilling and the use of allografts and xenografts. These techniques lead to the formation of soft fibrocartilaginous tissue which has limited long-term stability. Options for the treatment of damaged menisci currently include, surgery to remove the damaged portion of meniscus (20 years ago, before the meniscus was better understood, damaged menisci were removed completely), implantation of a plastic meniscus or using fibrin-glue to glue back the torn portion of meniscus. However, in plastic meniscal implants the use of hydrogels is often inadequate and there are problems with shear/stress forces on the implant. The use of fibrin glue is also unsatisfactory because the meniscus still contains a point of weakness and is a non-homogeneous anisotropic structure.
The relative failure of many surgical, synthetic and graft solutions has led to the growing interest in the development of cell-seeded repair systems for solving a number of clinical problems related to connective tissues such as articular cartilage, menisci and ligaments. These systems have also been called tissue-engineered repair systems. Typically autologous or allogenic cells are isolated from a tissue biopsy removed from a site remote from the injury. The cells are expanded in cell culture and seeded in a suitable 3D resorbable scaffold material, which when implanted into the defective or damaged site elicit a biological repair.
There are some reports describing in vitro and in vivo evaluation of cell-engineered systems for repair of load-bearing cartilaginous tissues. Examples of such systems have been described by Brittberg et al (
New England Journal of Medicine
331 889-95 (1994)), WO 89/00413, WO 90/09769, WO 91/16867, WO 90/12603, WO 95/31157 and Paige et al (
Plastic and Reconstructive Surgery
97(1) 168-180 (1996)).
Brittberg et al describe a procedure in which autologous chondrocytes, expanded in culture, are transferred into the defect. This procedure does not involve a scaffold material and thus a perios

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tissue implant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tissue implant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue implant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2553149

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.